Examkin

Question

Difficulty: HardPharmacologic Interventions

An intensive care unit team is urgently called to the bedside of a patient admitted yesterday for hepatic encephalopathy. The nurse reports that the patient just experienced a sudden, large-volume episode of hematemesis. The patient appears pale, diaphoretic, and minimally responsive. Current vital signs include a blood pressure of 84/46 mmHg, heart rate of 128/min, and respiratory rate of 24/min. While large-bore intravenous access is being secured and fluid resuscitation is underway, the team prepares for endotracheal intubation for airway protection. Pending an emergent esophagogastroduodenoscopy (EGD), which of the following pharmacologic interventions should be ordered immediately? (Select all that apply)

  1. Intravenous octreotideAnswer
  2. Intravenous ceftriaxoneAnswer
  3. Intravenous pantoprazoleAnswer
  4. D
    Enteral nadolol
  5. E
    Intravenous phytonadione

Answer

The correct immediate pharmacologic interventions are intravenous octreotide, intravenous ceftriaxone, and intravenous pantoprazole.
The correct multi-drug regimen for acute stabilization of suspected variceal hemorrhage includes intravenous octreotide to reduce splanchnic blood flow and portal pressure, an intravenous cephalosporin (ceftriaxone) to prevent infection and reduce mortality, and an intravenous proton pump inhibitor (pantoprazole) to treat potential coexisting peptic ulcer disease and stabilize clot formation in a neutral pH environment. All three must be initiated simultaneously alongside fluid and blood product resuscitation while awaiting endoscopy.

Step-by-Step Solution

1
Recognize the clinical syndrome.
The patient has a known history of decompensated cirrhosis and is now presenting with hemorrhagic shock due to presumed ruptured esophageal or gastric varices.
Identifying the etiology of the bleed in a cirrhotic patient dictates the specialized algorithmic approach to pharmacotherapy.
2
Select interventions that reduce portal pressures immediately.
Intravenous octreotide is selected.
Octreotide induces localized splanchnic vasoconstriction, which immediately reduces portal blood flow and variceal pressure, acting as a chemical tourniquet.
3
Address infectious complications unique to cirrhotic bleeding.
Intravenous ceftriaxone is selected.
Translocation of gut flora during a variceal bleed frequently causes spontaneous bacterial peritonitis, which is a major driver of mortality. Prophylactic antibiotics are a mandatory core intervention.
4
Provide empiric broad coverage for alternative bleeding sources.
Intravenous pantoprazole is selected.
Up to 20% of upper GI bleeds in cirrhotics are due to peptic ulcer disease rather than varices. High-dose PPI therapy stabilizes clots and treats potential ulcers until endoscopy provides definitive diagnosis.
5
Identify and withhold contraindicated routine liver medications.
Nadolol is withheld.
Non-selective beta-blockers prevent the compensatory tachycardia needed to maintain cardiac output in hemorrhagic shock.

Key Concept

The initial pharmacologic management of suspected variceal hemorrhage in a patient with cirrhosis involves a three-pronged approach: a splanchnic vasoconstrictor (octreotide), prophylactic antibiotics (ceftriaxone), and a proton pump inhibitor (pantoprazole).
Estimated Time:1m 30s
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic